ADVANCING VACCINES AND BIOTHERAPEUTICS

ABL has been ranked ‘Excellent’ for ELISPOT testing with EQAPOL external quality assurance program.

ABL scientists are working to conquer today’s most challenging diseases

ABL utilizes its strong core of product development expertise, GMP manufacturing and immunological testing capabilities toward advancing your candidate vaccines and therapeutics through preclinical and clinical development. ABL’s experts are producing and testing today’s leading oncolytic viruses, gene therapies, immunotherapies, viral vaccines, and recombinant protein vaccines.

ABL Europe

Biomanufacturing
Strasbourg, France & Lyon France

ABL, Inc.

Biomanufacturing & Immunology
Rockville, MD, USA

ABL Lyon

Immunology
Lyon, France

BIOMANUFACTURING

I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

IMMUNOBIOLOGY

I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

PRODUCT TYPES

Gene Therapies
Oncolytic Vectors
Vaccines
Immunotherapies

Click here to see our media

ABL IN THE NEWS

conference room (2)

Just - Evotec Biologics Partners With ABL On Development of Broadly Neutralising Antibody Against HIV

ABL, Inc. Supports Fill/Finish of SARS-CoV-2 (COVID-19) Vaccine Candidate

biomarker_500x350

ABL Continues to Support Race to find a Cure; SARS-CoV-2 (COVID-19) Vaccine Candidate

Themis collaborates with ABL Europe to manufacture its SARS-CoV-2 Vaccine Candidate in France